Liubing Hou
Shijiazhuang, 050000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Unraveling the pro-oncogenic role of GLIPR2: Its molecular basis in glioma malignancy.
Journal: Cellular signalling
Published: July 08, 2026
SMC3 Is Highly Expressed in Gliomas and Is Associated With Favorable Prognosis and B Cell-Related Immune Features.
Journal: Technology in cancer research & treatment
Published: May 27, 2026
Multi-Omic Analysis of Glioma Identifies RRM2 as a Prognostic Biomarker Associated With Tumor Stemness and Cell Cycle-Related Pathways.
Journal: Technology in cancer research & treatment
Published: May 16, 2026
Grade-Dependent Prognostic Value of Classical Clinicopathological Factors in Glioma: A Single-Center Retrospective Study.
Journal: Journal of clinical medicine
Published: April 25, 2026
Micro- and nanoplastic exposure and cancer: current evidence, mechanistic pathways, and translational challenges.
Journal: Translational cancer research
Published: April 15, 2026
Efficacy of radiotherapy combined with immunotherapy in driver gene-negative non-small cell lung cancer with brain metastases: A single-center retrospective analysis.
Journal: The Journal of international medical research
Published: March 26, 2026
Study on the expression, prognostic value, and molecular mechanisms of TIMP1 in glioma.
Journal: Cancer gene therapy
Published: November 25, 2025
CDK1 depletion suppresses glioma malignancy through cell cycle pathway regulation: Mechanistic insights from functional and molecular profiling.
Journal: Oncology reports
Published: August 21, 2025
CD9 regulates proliferation, invasion, migration and radioresistance of esophageal squamous cell carcinoma by activating AKT/GSK3β signaling pathway.
Journal: Frontiers in oncology
Published: May 19, 2025
Last Updated: 09/26/2026